Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Macrogenics (MGNX) Operating Margin (2016 - 2025)

Historic Operating Margin for Macrogenics (MGNX) over the last 14 years, with Q3 2025 value amounting to 25.59%.

  • Macrogenics' Operating Margin fell 233600.0% to 25.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 76.6%, marking a year-over-year increase of 34200.0%. This contributed to the annual value of 73.74% for FY2024, which is 2126400.0% up from last year.
  • According to the latest figures from Q3 2025, Macrogenics' Operating Margin is 25.59%, which was down 233600.0% from 165.27% recorded in Q2 2025.
  • Macrogenics' Operating Margin's 5-year high stood at 48.95% during Q3 2024, with a 5-year trough of 1763.06% in Q2 2024.
  • In the last 5 years, Macrogenics' Operating Margin had a median value of 303.85% in 2021 and averaged 325.77%.
  • Its Operating Margin has fluctuated over the past 5 years, first plummeted by -14207800bps in 2024, then soared by 15977900bps in 2025.
  • Over the past 5 years, Macrogenics' Operating Margin (Quarter) stood at 411.65% in 2021, then skyrocketed by 104bps to 16.39% in 2022, then tumbled by -2908bps to 460.39% in 2023, then skyrocketed by 71bps to 132.09% in 2024, then skyrocketed by 119bps to 25.59% in 2025.
  • Its Operating Margin stands at 25.59% for Q3 2025, versus 165.27% for Q2 2025 and 323.1% for Q1 2025.